Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prothena Corp Public (PRTA) Gains from Investment Securities: 2018-2025

Historic Gains from Investment Securities for Prothena Corp Public (PRTA) over the last 5 years, with Sep 2025 value amounting to $2,000.

  • Prothena Corp Public's Gains from Investment Securities fell 99.76% to $2,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year decrease of 71.11%. This contributed to the annual value of $3.2 million for FY2024, which is 16.75% down from last year.
  • Latest data reveals that Prothena Corp Public reported Gains from Investment Securities of $2,000 as of Q3 2025, which was down 99.79% from $941,000 recorded in Q2 2025.
  • Prothena Corp Public's Gains from Investment Securities' 5-year high stood at $3.5 million during Q3 2023, with a 5-year trough of -$2,000 in Q1 2025.
  • For the 3-year period, Prothena Corp Public's Gains from Investment Securities averaged around $880,333, with its median value being $760,000 (2024).
  • Its Gains from Investment Securities has fluctuated over the past 5 years, first spiked by 2,275.00% in 2022, then slumped by 110.00% in 2025.
  • Quarterly analysis of 5 years shows Prothena Corp Public's Gains from Investment Securities stood at $12,000 in 2021, then skyrocketed by 2,275.00% to $285,000 in 2022, then soared by 362.85% to $3.5 million in 2023, then slumped by 75.95% to $760,000 in 2024, then slumped by 99.76% to $2,000 in 2025.
  • Its Gains from Investment Securities was $2,000 in Q3 2025, compared to $941,000 in Q2 2025 and -$2,000 in Q1 2025.